My watch list
my.bionity.com  
Login  
NEWS
Current news

Highly effective antibodies against the coronavirus were identified

Berlin scientists lay basis for a passive vaccination

25-Sep-2020 Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité - Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination. In this process, they have also disco ... more

Unraveling the genome in 3D-space

Groundbreaking method to map contact points between replicated DNA molecules, thereby elucidating how the genome is folded inside the nucleus of human cells

25-Sep-2020 The cells that make up our body are tiny, each of them measuring only micrometers in diameter. The ensemble of chromosomal DNA molecules that encode the genome, on the other hand, measures almost 2 meters. In order to fit into cells, chromosomal DNA is folded many times. But the DNA is not ... more

The placebo effect meets the proteome

First study of the placebo effect at the molecular level, in the context of the relief of nausea

25-Sep-2020 The molecular bases of the placebo effect are poorly understood. A team led by LMU researcher Karin Meissner has now studied the phenomenon in the context of nausea, and identified specific proteins that correlate with its favorable impact. The placebo effect appears to work wonders. In cer ... more

Glycans in the SARS-CoV-2 spike protein play active role in infection

Results lay the foundation for new strategies to fight the pandemic threat

25-Sep-2020 As the COVID-19 pandemic rages on, researchers are working overtime to develop vaccines and therapies to thwart SARS-CoV-2, the virus responsible for the disease Many efforts focus on the coronavirus spike protein, which binds the angiotensin-converting enzyme 2 (ACE2) on human cells to all ... more

Mechanism that causes cell nuclei to grow discovered

24-Sep-2020 By far the most important process in cell development is how cells divide and then enlarge in order to multiply. A research team headed by Freiburg medical scientist Prof. Dr. Robert Grosse has now discovered that bundled fibers of actin within a cell nucleus play an important part in how t ... more

Danila Barskiy receives Sofja Kovalevskaja Award to develop low-cost portable spectroscopic devices

New approaches to promote the use of nuclear magnetic resonance spectroscopy for analysis in chemistry, biology, and medicine

24-Sep-2020 The diverse work of Mainz-based physicists in the field of nuclear magnetic resonance is being boosted by a new highly application-oriented approach: In October 2020, Dr. Danila Barskiy will join Johannes Gutenberg University Mainz (JGU) to set up a group focusing on nuclear magnetic resona ... more

For a climate-friendly industry: Using carbon dioxide and hydrogen as raw materials for sustainable chemicals

Evonik and Siemens Energy put pilot plant into operations

23-Sep-2020 Evonik and Siemens Energy commissioned a pilot plant sponsored by the German Federal Ministry of Education and Research (BMBF) that uses carbon dioxide and water to produce chemicals. The necessary energy is supplied by electricity from renewable sources. The pilot plant is located in Marl, ... more

Illumina to acquire start-up GRAIL

Launch new era of cancer detection

23-Sep-2020 Illumina, Inc. announced they have entered into a definitive agreement under which Illumina will acquire GRAIL for cash and stock consideration of $8 billion upon closing of the transaction. In addition, GRAIL stockholders will receive future payments representing a tiered single digit perc ... more

Unlocking the secrets of plant genomes in high resolution

New software tool allows for precise assignment to the correct copies – a process known as ‘phasing’

23-Sep-2020 Resolving genomes, particularly plant genomes, is a very complex and error-prone task. This is because there are several copies of all of the chromosomes and they are very alike. A team of bioinformatics researchers from Heinrich Heine University Düsseldorf (HHU) has now developed a softwar ... more

Method to safely study COVID-19, other contagious diseases developed

SARS-CoV-2 nanoparticle probes are used to study fundamental interactions between SARS-CoV-2 Spike proteins and human cells

22-Sep-2020 Scientists and researchers at the U.S. Naval Research Laboratory and National Center for Advancing Translational Sciences (NCATS), submitted their findings to ACS Nano on their collaboration to develop SARS-CoV-2 nanoparticle probes that are used to study fundamental interactions between SA ... more

All news

Unlocking the secrets of plant genomes in high resolution

New software tool allows for precise assignment to the correct copies – a process known as ‘phasing’

23-Sep-2020 Resolving genomes, particularly plant genomes, is a very complex and error-prone task. This is because there are several copies of all of the chromosomes and they are very alike. A team of bioinformatics researchers from Heinrich Heine University Düsseldorf (HHU) has now developed a softwar ... more

Bruker Announces Acquisition of Canopy Biosciences, LLC

Strengthens Bruker in Targeted Multi-Omics and High-Plex Biomarker Imaging

16-Sep-2020 Bruker Corporation announced the acquisition of Canopy Biosciences, LLC, a leader in high multiplex biomarker imaging for immunology, immuno-oncology and cell therapy. This acquisition enhances Bruker’s offering in targeted multi-omics and fluorescence-based imaging techniques. Bruker’s glo ... more

Leap forward in the fight against antibiotic resistance

Researchers succeed in deep sequencing RNA of single bacteria

21-Aug-2020 Bacteria show a wide range of capabilities in withstanding antibiotic treatment or attack by our immune system, which are great challenges in infection research. Scientists at the Würzburg-based Helmholtz Institute for RNA-based Infection Research (HIRI), a site of the Helmholtz Centre for ... more

analytica 2020: The world’s leading trade fair extends its reach with analytica virtual

First complementary laboratory fair

13-Aug-2020 analytica gets a digital extension. With the new format analytica virtual, the world’s leading trade fair for laboratory technology, analysis and biotechnology also enables those exhibitors and visitors to participate who due to travel restrictions cannot come to Munich. In addition, parts ... more

Tracking of new avian influenza viruses becomes possible through modern analyses of genome data

11-Aug-2020 An international consortium succeeded in tracking the genesis and spread of new reassortants of avian influenza viruses by the use of mathematical analyses. This large-scale international study has now been published in the scientific journal PNAS (Proceedings of the National Academy of Sci ... more

Researchers describe structure of SARS-CoV-2 proteins suitable for design of new drugs

04-Aug-2020 COVID-19 has changed the lives of millions and even billions of people around the world. The disease is caused by SARS coronavirus 2 (SARS-CoV-2), an RNA virus, i.e. a virus that uses RNA to store its genetic information. In order to confront it, we must have a detailed understanding of the ... more

Genetic key to "healthy" tea

Genome of an ancient tea tree elucidated and more than 200 different tea varieties analysed

03-Aug-2020 Tea (Camellia sinensis) is one of the world's most popular drinks with a wide range of flavours and health benefits. Researchers from Huazhong Agricultural University of Wuhan (China), Forschungszentrum Jülich, Heinrich Heine University Düsseldorf and the Max Planck Institute of Molecular P ... more

The genetic basis of bats’ superpowers revealed

First six reference-quality bat genomes released and analysed

24-Jul-2020 For the first time, the raw genetic material that codes for bats’ unique adaptations and superpowers such as the ability to fly, to use sound to move effortlessly in complete darkness, to survive and tolerate deadly diseases, to resist ageing and cancer - has been fully revealed. Bat1K, a g ... more

Formation of quadruple helix DNA tracked in live human cells for the first time

The biology of DNA must be rethink

23-Jul-2020 The formation of four-stranded DNA has been tracked in living human cells, allowing scientists to see how it works, and its possible role in cancer. DNA usually forms the classic double helix shape discovered in 1953 - two strands wound around each other. Several other structures have been ... more

How smart, ultrathin nanosheets go fishing for proteins

Faster and simpler production of high-resolution, three-dimensional electron microscopy images of biomolecules

21-Jul-2020 An interdisciplinary team from Frankfurt and Jena has developed a kind of bait with which to fish protein complexes out of mixtures. Thanks to this “bait”, the desired protein is available much faster for further examination in the electron microscope. The research team has christened this ... more

All news on bioanalytics

For a climate-friendly industry: Using carbon dioxide and hydrogen as raw materials for sustainable chemicals

Evonik and Siemens Energy put pilot plant into operations

23-Sep-2020 Evonik and Siemens Energy commissioned a pilot plant sponsored by the German Federal Ministry of Education and Research (BMBF) that uses carbon dioxide and water to produce chemicals. The necessary energy is supplied by electricity from renewable sources. The pilot plant is located in Marl, ... more

Start-up Inflazome Announces Acquisition by Roche

Orally available NLRP3 inflammasome inhibitors to address clinical unmet needs across a wide variety of inflammatory diseases

22-Sep-2020 Inflazome announced that it has closed a share purchase agreement with Roche  in which Inflazome’s shareholders received an upfront payment of €380 million, and are eligible to receive additional contingent payments to be made based on the achievement of certain predetermined milestones.  I ... more

Are bioplastics and plant-based materials safer than conventional plastics?

Biomaterials contain up to 20.000 chemicals

21-Sep-2020 So-called “bioplastics” are marketed as an environmentally friendly alternative to conventional, petroleum-based plastics. They can be made from renewable feedstock, might be bio-degradable or even both. The question is however if these biomaterials are safer than conventional plastics with ... more

Merck Well-Positioned for Further Growth

From today’s perspective targeted smaller to medium-sized acquisitions after 2022 more likely than major transformative deals

17-Sep-2020 Merck expects to deliver continued profitable growth in the coming years despite a challenging market environment. Today at its virtual Capital Markets Day, the company presented to analysts and investors the progress made in realizing the growth and expansion phase of its strategy for the ... more

Tiny helpers turn waste into valuable materials

Leaving oil behind and moving towards renewable raw materials: the chemical industry hopes to succeed in this with the help of microorganisms and enzymes

15-Sep-2020 The idea is that bacteria shouldn’t only convert waste products into valuable chemicals, but also draw energy from them. After all, they too can be reused for subsequent processes. This vision is what drives Professor Dirk Tischler, who heads the Microbial Biotechnology research group at Ru ... more

Let there be light and the process stops

Easy method for dynamically controlling biotechnological substance production

15-Sep-2020 ETH researchers have discovered that they can use light-​sensitive molecules to switch genetic networks on and off as required. Their finding gives rise to an easy method for dynamically controlling biotechnological substance production. Tetracycline (Tc), an antibiotic, and its derivative ... more

Merck Announces € 59 Million Antibody-Drug Conjugate Manufacturing Expansion

Creates one of the largest single-digit nanogram containment manufacturing facilities for high-potent active pharmaceutical ingredient (HPAPI) production

10-Sep-2020 Merck announced a € 59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin, USA. This investment will allow large-scale manufacturing of increasingly potent compounds for therapies that have the potential to treat cancer. Co ... more

Producing leather-like materials from fungi

Biofabrication includes upcycling of low-cost agricultural and forestry by-products

09-Sep-2020 Leather is used as a durable and flexible material in many aspects of everyday life including furniture and clothing. Leather substitutes derived from fungi are considered to be an ethical and environmentally friendly alternative to traditional bovine leather. An international team led by m ... more

BioNTech and Pfizer test COVID-19 Vaccine Candidate in Germany

Regulatory Approval From Paul-Ehrlich-Institut to Commence German Part of Global Phase 2/3 Trial Received

08-Sep-2020 BioNTech SE and Pfizer Inc. announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the Phase 2/3 clinical trial in Germany for their BNT162b2 vaccine candidate. The study in Germany is part of the global pivotal Phase 2/3 program BioNTech and Pfizer initiate ... more

Inheritance in Plants Can Now Be Controlled Specifically

For the First Time, Researchers Use CRISPR/Cas Molecular Scissors to Recombine Genes on a Chromosome

08-Sep-2020 A new application of the CRISPR/Cas molecular scissors promises major progress in crop cultivation. At Karlsruhe Institute of Technology (KIT), researchers from the team of molecular biologist Holger Puchta have succeeded in modifying the sequence of genes on a chromosome using CRISPR/Cas. ... more

All news on biotechnology

Illumina to acquire start-up GRAIL

Launch new era of cancer detection

23-Sep-2020 Illumina, Inc. announced they have entered into a definitive agreement under which Illumina will acquire GRAIL for cash and stock consideration of $8 billion upon closing of the transaction. In addition, GRAIL stockholders will receive future payments representing a tiered single digit perc ... more

QIAGEN fully acquires NeuMoDx Molecular

QIAGEN acquires remaining 80.1% stake in NeuMoDx Molecular, Inc. for $248 million

18-Sep-2020 QIAGEN N.V. announced the acquisition of the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular, Inc. for $248 million in cash. The move rounds out QIAGEN’s portfolio of automated molecular testing solutions based on the proven PCR technology. The transaction was completed ... more

“Honey, I shrunk the detector”

Researchers have developed the world’s smallest ultrasound detector

18-Sep-2020 Researchers at Helmholtz Zentrum München and the Technical University of Munich (TUM) have developed the world’s smallest ultrasound detector. It is based on miniaturized photonic circuits on top of a silicon chip. With a size 100 times smaller than an average human hair, the new detector c ... more

New software detects disease-causing gene mutations

Software finds "needle in a haystack" e.g. in the diagnosis of rare diseases

10-Sep-2020 A serious illness is often the result of a single genetic defect. But given that two healthy people already have around three million differences in their genetic make-up, it is no easy task to pick out the one disease-causing deviation from the many harmless gene variants. Scientists at th ... more

Towards a cell-based interceptive medicine in Europe

Diagnose diseases earlier and intercept disorders before irreparable damage occurs

09-Sep-2020 Hundreds of researchers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare. In a perspective in Nature and the LifeTime Strategic Research Agenda they now present a roadmap of how to leverage the latest scientific ... more

Attacking tumours directly on identification

Therapy and diagnostics of tumours in only one step is possible with the aid of so-called theranostic agents

04-Sep-2020 The combination of a biomolecule and a metal complex can target, bind, mark and damage cancer cells. A German-Spanish team has manufactured such a theranostic agent that visualises tumour cells by irradiation with visible light, and proved its effectiveness against lung cancer cells. Andres ... more

analytica 2020: World’s leading trade fair to be held virtually

analytica virtual to take the place of the presence fair in Munich

02-Sep-2020 This year, Messe München is hosting the world’s leading trade fair for laboratory technology, analysis and biotechnology as a virtual event. The new format analytica virtual will enable exhibitors to book digital trade fair booths for October 19 to 23. Furthermore, it offers all customers a ... more

Portable, point-of-care COVID-19 test could bypass the lab

Researchers developed a microfluidic cartridge for a 30-minute COVID-19 test

02-Sep-2020 As COVID-19 continues to spread, bottlenecks in supplies and laboratory personnel have led to long waiting times for results in some areas. In a new study, University of Illinois, Urbana-Champaign researchers have demonstrated a prototype of a rapid COVID-19 molecular test and a simple-to-u ... more

Spin-off from Charité want to advance AI-powered pathology

Aignostics Raises €5 Million Seed Round

31-Aug-2020 Aignostics, a spin-off from Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) pioneering computational pathology for pharmaceutical research and diagnostics, has announced the closing of a €5 M seed round funding. Boehringer Ingelheim Venture Fund (BIVF) led the ... more

Immune response to Sars-Cov-2 following organ transplantation

Even patients with suppressed immune systems can achieve a strong immune response to Sars-Cov-2: A test helps to adapt therapy following an infection

19-Aug-2020 A research team from the University Hospital at Ruhr-Universität Bochum (RUB) has developed a test that provides information on the immune response to the novel coronavirus in patients who need to take immunosuppressive drugs. This is necessary, for instance, following an organ transplantat ... more

All news on diagnostics

analytica 2020: World’s leading trade fair to be held virtually

analytica virtual to take the place of the presence fair in Munich

02-Sep-2020 This year, Messe München is hosting the world’s leading trade fair for laboratory technology, analysis and biotechnology as a virtual event. The new format analytica virtual will enable exhibitors to book digital trade fair booths for October 19 to 23. Furthermore, it offers all customers a ... more

Eppendorf AG records strong first half-year 2020

Coronavirus pandemic drives demand for consumables and pipetting robots

26-Aug-2020 The globally active Eppendorf Group was once again able to increase its consolidated revenue in the first half of 2020. Despite the global restrictions necessitated by the coronavirus pandemic, revenue grew by 6.6% to €403.7 million (prior-year: €378.5 million). Operating profit (EBIT) in t ... more

analytica 2020: The world’s leading trade fair extends its reach with analytica virtual

First complementary laboratory fair

13-Aug-2020 analytica gets a digital extension. With the new format analytica virtual, the world’s leading trade fair for laboratory technology, analysis and biotechnology also enables those exhibitors and visitors to participate who due to travel restrictions cannot come to Munich. In addition, parts ... more

Sartorius raises forecast for the full year of 2020

Stronger growth and higher profitability expected for the Bioprocess Solutions Division and the entire Group

17-Jul-2020 Based on the strong performance of the Bioprocess Solutions Division in the first half of 2020 as well as on high demand also expected to continue for the rest of the current fiscal year, Sartorius raised its full-year sales and earnings guidance for this division and thus for the entire Gr ... more

InnoME and Etaluma Announce Imaging Strategic Partnership

Very simple time lapse experiments in 24 and 6-well microplates as well as flasks and dishes

14-Jul-2020 InnoME, Gmbh and Etaluma, Inc. announced a partnership to bring entry level incubator cell imaging to the Americas.  Etaluma will exclusively offer InnoME’s zenCell technology as the “lumanette”. The lumanette provides 24 individual 10x imagers for very simple time lapse experiments in 24 a ... more

LGC acquires The Native Antigen Company

Strengthening LGC'S offer to the IVD sector

10-Jul-2020 LGC announced the acquisition of The Native Antigen Company (NAC), supplier of high quality infectious disease antigens and antibodies. NAC is a developer, manufacturer and supplier of critical reagents to the in vitro diagnostic (IVD), pharmaceutical and academic sectors. It offers a compr ... more

analytica 2020: Great exhibitor resonance for the autumnal fair

Trade fair to implement the government’s protection and hygiene concept

30-Jun-2020 After the postponement to the fall, there are now increasing signs for a success of analytica in October. The number of exhibitors has currently almost reached the level of the previous event. Most recently, the Bavarian State Government has cleared the way for analytica: From September 01 ... more

Eppendorf acquires centrifuge business of Koki Holdings Co., Ltd.

20-Mar-2020 Eppendorf AG and Koki Holdings Co., Ltd., have reached an agreement that Eppendorf will acquire Koki’s centrifuge business, including the premium himac brand. A corresponding agreement was signed by both companies in Tokyo. The acquisition marks a targeted step by Hamburg-based Eppendorf AG ... more

analytica 2020 is postponed

New date in the fall of 2020

09-Mar-2020 Due to the increasing spread of the coronavirus (COVID-19) in Europe and on the basis of the recommendations of the Bavarian State Government as well as of the responsible health authorities, Messe München feels compelled to postpone analytica 2020. This measure is taken in consultation wit ... more

Wolfgang Kintzel to Become Cellbox Solutions’ CEO

26-Feb-2020 Cellbox Solutions announces the expansion of its Board of Directors and the appointment of a new CEO - Wolfgang Kintzel will start as Chief Executive Officer effective March 1, 2020. The founder Prof. Kathrin Adlkofer will support the board in the function as COO. Wolfgang Kintzel has an ex ... more

All news on laborausstattung / laborbedarf

Start-up Inflazome Announces Acquisition by Roche

Orally available NLRP3 inflammasome inhibitors to address clinical unmet needs across a wide variety of inflammatory diseases

22-Sep-2020 Inflazome announced that it has closed a share purchase agreement with Roche  in which Inflazome’s shareholders received an upfront payment of €380 million, and are eligible to receive additional contingent payments to be made based on the achievement of certain predetermined milestones.  I ... more

Spin-off project successfully developed a COVID-19 vaccine candidate

Quick, efficient and scalable vaccine manufacturing: virus-like particle developed and produced

17-Sep-2020 With the current pandemic crisis, the lack of worldwide vaccine manufacturing capacity has become a serious concern. ContiVir, a spin-off project at the Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg, has successfully produced a virus-like particle as a COVID-19 va ... more

Merck Well-Positioned for Further Growth

From today’s perspective targeted smaller to medium-sized acquisitions after 2022 more likely than major transformative deals

17-Sep-2020 Merck expects to deliver continued profitable growth in the coming years despite a challenging market environment. Today at its virtual Capital Markets Day, the company presented to analysts and investors the progress made in realizing the growth and expansion phase of its strategy for the ... more

Seattle Genetics and Merck & Co Announce Two Strategic Oncology Collaborations

Merck to Acquire $1 Billion Equity Stake in Seattle Genetics Common Stock

16-Sep-2020 Seattle Genetics, Inc. and Merck, known as MSD outside the United States and Canada, announced two new strategic oncology collaborations. The companies will globally develop and commercialize Seattle Genetics’ ladiratuzumab vedotin, an investigational antibody-drug conjugate (ADC) targeting ... more

Gilead Sciences to Acquire Immunomedics

Trodelvy will Accelerate Gilead’s Emerging and Complementary Oncology Pipeline

15-Sep-2020 Gilead Sciences, Inc. and Immunomedics announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Immunomedics for $88.00 per share in cash. The transaction, which values Immunomedics at approximately $21 billion, was unanimously approved by ... more

Bayer: Supervisory Board extends CEO Werner Baumann’s

Contract until the end of April 2024

14-Sep-2020 The Supervisory Board of Bayer AG has unanimously decided to extend the contract of Werner Baumann, Chairman of the Board of Management, until April 30, 2024. Before the extension, Baumann’s contract would have expired at the 2021 Annual Stockholders’ Meeting. Baumann, 57, has worked for Ba ... more

BioNTech and Pfizer test COVID-19 Vaccine Candidate in Germany

Regulatory Approval From Paul-Ehrlich-Institut to Commence German Part of Global Phase 2/3 Trial Received

08-Sep-2020 BioNTech SE and Pfizer Inc. announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the Phase 2/3 clinical trial in Germany for their BNT162b2 vaccine candidate. The study in Germany is part of the global pivotal Phase 2/3 program BioNTech and Pfizer initiate ... more

Chemist developed a green catalyst for pharmaceutical and industrial chemistry

Catalyst based on a substance that comes from plant waste

08-Sep-2020 Many production facilities (e.g. plastic manufacturers, pharma companies, and others) use nanocatalysts that contain palladium--an expensive component that is not sustainably produced. A chemist from RUDN University found a way to reduce palladium consumption and to make its manufacture mor ... more

CureVac Expected to Receive up to 252 million Euros from the German Federal Ministry of Research

Further COVID-19 Vaccine Development and Production Capacity Expansion

07-Sep-2020 CureVac N.V. has received notification from the German Federal Ministry of Education and Research (BMBF) that CureVac is expected receive up to 252 million euros to support the development of its COVID-19 vaccine candidate. In July 2020, CureVac had applied to a grant as part of a special p ... more

Start-up develops novel next-generation immuno oncology treatments

Bayer and Northpond Ventures lead USD 55 million Series A financing round

31-Aug-2020 Triumvira Immunologics Inc. (“Triumvira”), a privately-held biopharmaceutical company developing a novel platform for engineering T-cells to attack cancers, successfully completed a USD 55 million Series A financing round. The financing was co-led by Leaps by Bayer, the impact investment un ... more

All news on pharma

Highly effective antibodies against the coronavirus were identified

Berlin scientists lay basis for a passive vaccination

25-Sep-2020 Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité - Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination. In this process, they have also disco ... more

The placebo effect meets the proteome

First study of the placebo effect at the molecular level, in the context of the relief of nausea

25-Sep-2020 The molecular bases of the placebo effect are poorly understood. A team led by LMU researcher Karin Meissner has now studied the phenomenon in the context of nausea, and identified specific proteins that correlate with its favorable impact. The placebo effect appears to work wonders. In cer ... more

Glycans in the SARS-CoV-2 spike protein play active role in infection

Results lay the foundation for new strategies to fight the pandemic threat

25-Sep-2020 As the COVID-19 pandemic rages on, researchers are working overtime to develop vaccines and therapies to thwart SARS-CoV-2, the virus responsible for the disease Many efforts focus on the coronavirus spike protein, which binds the angiotensin-converting enzyme 2 (ACE2) on human cells to all ... more

Method to safely study COVID-19, other contagious diseases developed

SARS-CoV-2 nanoparticle probes are used to study fundamental interactions between SARS-CoV-2 Spike proteins and human cells

22-Sep-2020 Scientists and researchers at the U.S. Naval Research Laboratory and National Center for Advancing Translational Sciences (NCATS), submitted their findings to ACS Nano on their collaboration to develop SARS-CoV-2 nanoparticle probes that are used to study fundamental interactions between SA ... more

Why we need sleep

In very early life, sleep helps build the brain's infrastructure, but it then takes on an entirely new decluttering role

22-Sep-2020 Prolonged sleep deprivation can lead to severe health problems in humans and other animals. But why is sleep so vital to our health? A UCLA-led team of scientists has answered this question and shown for the first time that a dramatic change in the purpose of sleep occurs at the age of abou ... more

Increasing the effectiveness of immunotherapy against skin cancer

Efficacy of immune checkpoint inhibitors can be improved by the simultaneous administration of IL-32

22-Sep-2020 Researchers at the University of Bern have discovered a mechanism in the body’s own immune system which is responsible for the maturation and activation of immune cells. In the fight against skin cancer, the results have the potential to help immunotherapies succeed, even in patients for wh ... more

Risk gene for Alzheimer’s has early effects on the brain

Results of a study in 82 young adults

21-Sep-2020 A genetic predisposition to late-onset Alzheimer’s disease affects how the brains of young adults cope with certain memory tasks. Researchers from the German Center for Neurodegenerative Diseases (DZNE) and the Ruhr-Universität Bochum report on this in the scientific journal “Current Biolog ... more

Antibiotic interaction testing made easy

New high-speed test shows how antibiotics combine to kill bacteria

21-Sep-2020 Researchers at Uppsala University have developed a new method to determine - rapidly, easily and cheaply - how effective two antibiotics combined can be in stopping bacterial growth. The new method is simple for laboratories to use and can provide greater scope for customising treatment of ... more

Stem cell research delivers new points of attack against Parkinson’s disease

Lack of protein DJ-1 makes you sick

18-Sep-2020 In a seven-year research effort, an international team of scientists has clarified the cause for certain genetic forms of Parkinson’s disease, and has identified potential pharmacological treatments. The interdisciplinary research team, led by Prof. Rejko Krüger, of the Luxembourg Centre fo ... more

A protein for the mass production of antibodies

Rare genetic defect provides fundamental knowledge about antibodies

17-Sep-2020 Scientists from the Institute of Molecular Biology of the Austrian Academy of Sciences and the University of British Columbia have discovered a major role of the protein JAGN1 in antibody production and the body’s ability to mount a defense against pathogens, including viruses. Antibodies ... more

All news on healthcare
News by department
  • Products

    For a climate-friendly industry: Using carbon dioxide and hydrogen as raw materials for sustainable chemicals

    Evonik and Siemens Energy put pilot plant into operations

    23-Sep-2020 Evonik and Siemens Energy commissioned a pilot plant sponsored by the German Federal Ministry of Education and Research (BMBF) that uses carbon dioxide and water to produce chemicals. The necessary energy is supplied by electricity from renewable sources. The pilot plant is located in Marl, ... more

    Spin-off project successfully developed a COVID-19 vaccine candidate

    Quick, efficient and scalable vaccine manufacturing: virus-like particle developed and produced

    17-Sep-2020 With the current pandemic crisis, the lack of worldwide vaccine manufacturing capacity has become a serious concern. ContiVir, a spin-off project at the Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg, has successfully produced a virus-like particle as a COVID-19 va ... more

    BioNTech and Pfizer test COVID-19 Vaccine Candidate in Germany

    Regulatory Approval From Paul-Ehrlich-Institut to Commence German Part of Global Phase 2/3 Trial Received

    08-Sep-2020 BioNTech SE and Pfizer Inc. announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the Phase 2/3 clinical trial in Germany for their BNT162b2 vaccine candidate. The study in Germany is part of the global pivotal Phase 2/3 program BioNTech and Pfizer initiate ... more

  • Business

    For a climate-friendly industry: Using carbon dioxide and hydrogen as raw materials for sustainable chemicals

    Evonik and Siemens Energy put pilot plant into operations

    23-Sep-2020 Evonik and Siemens Energy commissioned a pilot plant sponsored by the German Federal Ministry of Education and Research (BMBF) that uses carbon dioxide and water to produce chemicals. The necessary energy is supplied by electricity from renewable sources. The pilot plant is located in Marl, ... more

    Illumina to acquire start-up GRAIL

    Launch new era of cancer detection

    23-Sep-2020 Illumina, Inc. announced they have entered into a definitive agreement under which Illumina will acquire GRAIL for cash and stock consideration of $8 billion upon closing of the transaction. In addition, GRAIL stockholders will receive future payments representing a tiered single digit perc ... more

    Start-up Inflazome Announces Acquisition by Roche

    Orally available NLRP3 inflammasome inhibitors to address clinical unmet needs across a wide variety of inflammatory diseases

    22-Sep-2020 Inflazome announced that it has closed a share purchase agreement with Roche  in which Inflazome’s shareholders received an upfront payment of €380 million, and are eligible to receive additional contingent payments to be made based on the achievement of certain predetermined milestones.  I ... more

  • Price Development

    Are the high prices of cancer drugs justified?

    Does the cost correspond to the particular drug’s effectiveness in combating the disease?

    05-May-2020 Do high prices of some cancer medicines have a higher benefit than those drugs with lower prices? An international UZH study has concluded that, in general, there is no correlation between costs of a cancer drugs and their clinical benefit. The researchers are therefore calling for the clin ... more

    Drug costs vary by more than 600% in study of 10 high-income countries

    13-Jun-2017 In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more

    Cell Medica granted Orphan Drug designation for novel cellular therapy

    18-Mar-2015 Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more

  • Research

    Highly effective antibodies against the coronavirus were identified

    Berlin scientists lay basis for a passive vaccination

    25-Sep-2020 Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité - Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination. In this process, they have also disco ... more

    Unraveling the genome in 3D-space

    Groundbreaking method to map contact points between replicated DNA molecules, thereby elucidating how the genome is folded inside the nucleus of human cells

    25-Sep-2020 The cells that make up our body are tiny, each of them measuring only micrometers in diameter. The ensemble of chromosomal DNA molecules that encode the genome, on the other hand, measures almost 2 meters. In order to fit into cells, chromosomal DNA is folded many times. But the DNA is not ... more

    The placebo effect meets the proteome

    First study of the placebo effect at the molecular level, in the context of the relief of nausea

    25-Sep-2020 The molecular bases of the placebo effect are poorly understood. A team led by LMU researcher Karin Meissner has now studied the phenomenon in the context of nausea, and identified specific proteins that correlate with its favorable impact. The placebo effect appears to work wonders. In cer ... more

  • People

    Bayer: Supervisory Board extends CEO Werner Baumann’s

    Contract until the end of April 2024

    14-Sep-2020 The Supervisory Board of Bayer AG has unanimously decided to extend the contract of Werner Baumann, Chairman of the Board of Management, until April 30, 2024. Before the extension, Baumann’s contract would have expired at the 2021 Annual Stockholders’ Meeting. Baumann, 57, has worked for Ba ... more

    CureVac Appoints Dr. Franz-Werner Haas as Chief Executive Officer

    Dr. Igor Splawski as Chief Scientific Officer appointed

    05-Aug-2020 CureVac announced that Dr. Franz-Werner Haas, previously acting Chief Executive Officer and Chief Operating Officer (COO), has been appointed Chief Executive Officer (CEO). Before Dr. Haas joined CureVac in June 2012, he worked as Vice President Operations and Chief Compliance Officer of SY ... more

    Waters Corporation Names Udit Batra President and Chief Executive Officer

    Dr. Batra succeeds Christopher O’Connell

    17-Jul-2020 Waters Corporation announced that Udit Batra, Ph.D. has been named the Company’s President and Chief Executive Officer, effective September 1, 2020. He will also join Waters’ Board of Directors at that time. Dr. Batra succeeds Christopher O’Connell who will remain in his current roles as Pr ... more

  • Finances

    Merck Well-Positioned for Further Growth

    From today’s perspective targeted smaller to medium-sized acquisitions after 2022 more likely than major transformative deals

    17-Sep-2020 Merck expects to deliver continued profitable growth in the coming years despite a challenging market environment. Today at its virtual Capital Markets Day, the company presented to analysts and investors the progress made in realizing the growth and expansion phase of its strategy for the ... more

    Spin-off from Charité want to advance AI-powered pathology

    Aignostics Raises €5 Million Seed Round

    31-Aug-2020 Aignostics, a spin-off from Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) pioneering computational pathology for pharmaceutical research and diagnostics, has announced the closing of a €5 M seed round funding. Boehringer Ingelheim Venture Fund (BIVF) led the ... more

    Start-up develops novel next-generation immuno oncology treatments

    Bayer and Northpond Ventures lead USD 55 million Series A financing round

    31-Aug-2020 Triumvira Immunologics Inc. (“Triumvira”), a privately-held biopharmaceutical company developing a novel platform for engineering T-cells to attack cancers, successfully completed a USD 55 million Series A financing round. The financing was co-led by Leaps by Bayer, the impact investment un ... more

  • Cooperation

    For a climate-friendly industry: Using carbon dioxide and hydrogen as raw materials for sustainable chemicals

    Evonik and Siemens Energy put pilot plant into operations

    23-Sep-2020 Evonik and Siemens Energy commissioned a pilot plant sponsored by the German Federal Ministry of Education and Research (BMBF) that uses carbon dioxide and water to produce chemicals. The necessary energy is supplied by electricity from renewable sources. The pilot plant is located in Marl, ... more

    Seattle Genetics and Merck & Co Announce Two Strategic Oncology Collaborations

    Merck to Acquire $1 Billion Equity Stake in Seattle Genetics Common Stock

    16-Sep-2020 Seattle Genetics, Inc. and Merck, known as MSD outside the United States and Canada, announced two new strategic oncology collaborations. The companies will globally develop and commercialize Seattle Genetics’ ladiratuzumab vedotin, an investigational antibody-drug conjugate (ADC) targeting ... more

    Evotec and Novo Nordisk form alliance to develop novel therapies for kidney diseases

    Milestone potential of more than € 150 m per product

    19-Aug-2020 Evotec SE and Novo Nordisk announced a strategic collaboration on the discovery and development of innovative therapeutics for patients with chronic kidney disease. Evotec and Novo Nordisk will jointly identify and develop novel targets based on comprehensive medical and molecular data sets ... more

  • Technology

    LGC acquires The Native Antigen Company

    Strengthening LGC'S offer to the IVD sector

    10-Jul-2020 LGC announced the acquisition of The Native Antigen Company (NAC), supplier of high quality infectious disease antigens and antibodies. NAC is a developer, manufacturer and supplier of critical reagents to the in vitro diagnostic (IVD), pharmaceutical and academic sectors. It offers a compr ... more

    Domain Therapeutics is granted European and US patent for biosensors assessing GPCR trafficking

    05-Feb-2020 Domain Therapeutics announced that it has been granted a patent in the US and in Europe covering a novel family of biosensors.   The patent, entitled ‘Biosensors for monitoring biomolecule localization and trafficking in cells’, was initially filed by Prof. Michel Bouvier and his team and i ... more

    Printing nanoparticle shapes for medical applications

    18-Apr-2019 Personal drug delivery or nano-robotic systems could be a key concept for future medical applications. In this context, scientists around David Ng (Department of Prof. Tanja Weil) of the Max Planck Institute for Polymer Research (MPI-P) have recently developed a technology to customize the ... more

  • Laws

    Japan and Singapore Grant CRISPR Patents to Merck

    27-Nov-2019 Merck announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company’s patent application for the use of paired CRISPR nickases, bringing Merck’s number of patents to 22 worldwide. “Paired nickases represent a significant step in incre ... more

    Restriction of hazardous substances in tattoo inks

    15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more

    Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

    05-Mar-2019 Merck announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells. The patent provides an important and more specific solution for scientists who need accurate methods when developing treatments for diffi ... more

  • Market

    M&A in chemicals and life sciences slowed down by global lockdowns

    Race for COVID-19 vaccine

    13-Jul-2020 In the first half of this year, the transaction volume of mergers and acquisitions in the chemical and life sciences industries has decreased dramatically. The volume of deals announced in the first six months is only $84 billion. Compared to the previous year (389 billion dollars), this is ... more

    Many of the deadliest cancers receive the least amount of research funding

    'Embarrassing' or stigmatized cancers like lung and liver are underfunded

    23-Jul-2019 Many of the deadliest or most common cancers get the least amount of nonprofit research funding, according to a new Northwestern Medicine study that examined the distribution of nonprofit research funding in 2015 across cancer types. Colon, endometrial, liver and bile duct, cervical, ovaria ... more

    Gene Editing Tools Gain an Uptick in Sales With Emphasis on Rare Genetic Disorder Management

    22-Jul-2019 According to latest research by FMI, the global gene editing tools market is estimated to have accounted for more than US$ 258 Mn in terms of value in 2018. The report on the gene editing tools market further projects that the gene editing tools market is likely to grow at a CAGR of over 18 ... more

  • Politics

    Restriction of hazardous substances in tattoo inks

    15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more

    ECETOC Task Force provides new insights

    Toxicity testing of microparticles and poorly soluble liquids in the water environment

    15-Jan-2019 A Task Force set up by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) has provided new insights into scientific testing for the impact of undissolved particles in the aquatic environment. ECETOC launched the Task Force in response to increasing concerns among the ... more

    15 emerging technologies that could reduce global catastrophic biological risks

    11-Oct-2018 Strategic investment in 15 promising technologies could help make the world better prepared and equipped to prevent future infectious disease outbreaks from becoming catastrophic events. This subset of emerging technologies and their potential application are the focus of a new report, Tech ... more

  • Manufacturing

    LANXESS plans to expand capacity for Oxone monopersulfate - a main active ingredient for disinfectants

    Significant increase in demand due to African swine fever and corona pandemic

    16-Sep-2020 Due to the continuous strong demand for disinfectants, specialty chemicals company LANXESS is planning to expand its production capacity for Oxone monopersulfate by around 50 percent. To this end, the company intends to invest a lower double-digit million euro sum in its production facility ... more

    Merck Announces € 59 Million Antibody-Drug Conjugate Manufacturing Expansion

    Creates one of the largest single-digit nanogram containment manufacturing facilities for high-potent active pharmaceutical ingredient (HPAPI) production

    10-Sep-2020 Merck announced a € 59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin, USA. This investment will allow large-scale manufacturing of increasingly potent compounds for therapies that have the potential to treat cancer. Co ... more

    Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe

    29-Jul-2020 Sandoz, the Novartis generics and biosimilars division, is pleased to announce plans for a joint investment, together with the Austrian federal government, to strengthen the long-term future of integrated antibiotics manufacturing in Europe. Sandoz CEO Richard Saynor said: “This plan is a g ... more

  • Career

    Eppendorf with worldwide setting program

    Around 250 vacancies at all locations by the end of 2019

    26-Apr-2019 The Eppendorf Group is creating around 250 new jobs worldwide this year. A large proportion of the new jobs will be created in Hamburg at the headquarters of the globally active life sciences company and is an important component of Eppendorf's growth strategy. "Eppendorf is growing strongl ... more

    Lower pension, shorter life

    12-Apr-2019 Income and social status have an increasing effect on life expectancy in Germany. On average, men with very low retirement pay die five years earlier than those who are much better off. Poverty shortens life. According to a study by researchers at the Max Planck Institute for Demographic Re ... more

    KNAUER among the top one percent of employers in Germany

    28-Feb-2019 In the study "Leading Employers Germany 2019", the Berlin-based manufacturer of high-tech laboratory measuring instruments KNAUER was ranked as one of the best employers for the second time. This makes KNAUER one of the companies with the best ratings in an independent meta-study conducted ... more

News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE